# Enumeral Biomedical Holdings, Inc.

Enumeral Biomedical Holdings, Inc. is a company headquartered in Arlington, MA, United States.

## Company overview

- **Legal name:** Enumeral Biomedical Holdings, Inc.
- **Former names in filing history:** CERULEAN GROUP, INC. (2013-01-04 to 2014-06-16)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Arlington, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001561551

## About

Enumeral Biomedical Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001561551, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2017-03-28, it reported net income of USD -11,856,231; total assets of USD 4,947,218 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Net income:** -$11.9M (USD -11,856,231)
- **Total assets:** $4.9M (USD 4,947,218)
- **Cash and equivalents:** $3.2M (USD 3,162,400)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $1.5M (USD 1,489,385)
- **Net income:** $3.3M (USD 3,290,004)
- **Total assets:** $6.3M (USD 6,343,598)
- **Cash and equivalents:** $3.6M (USD 3,596,262)
- **Operating cash flow:** -$9.3M (USD -9,285,052)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $164,026 (USD 164,026)
- **Net income:** -$8.2M (USD -8,179,410)
- **Total assets:** $15.5M (USD 15,534,970)
- **Cash and equivalents:** $10.5M (USD 10,460,117)
- **Operating cash flow:** -$5.2M (USD -5,238,414)

### FY2013 (period ended 2013-10-31)

- **Net income:** -$19,406 (USD -19,406)
- **Total assets:** $23,728 (USD 23,728)
- **Cash and equivalents:** $17,902 (USD 17,902)
- **Operating cash flow:** -$23,232 (USD -23,232)

## Recent SEC filings

- Form 8-K — filed 2018-01-29 — period 2018-01-26 — 8-K
- Form 8-K — filed 2017-12-19 — period 2017-12-18 — 8-K
- Form 10-Q — filed 2017-11-14 — period 2017-09-30 — 10-Q
- Form 8-K — filed 2017-10-31 — period 2017-10-27 — 8-K
- Form 8-K — filed 2017-10-27 — period 2017-10-23 — 8-K
- Form 8-K — filed 2017-09-22 — period 2017-09-19 — 8-K
- Form 8-K — filed 2017-09-05 — period 2017-09-01 — 8-K
- Form 8-K — filed 2017-08-25 — period 2017-08-23 — 8-K
- Form 8-K — filed 2017-08-14 — period 2017-08-14 — FORM 8-K
- Form 10-Q — filed 2017-08-14 — period 2017-06-30 — 10-Q
- Form 8-K — filed 2017-08-03 — period 2017-07-31 — 8-K
- Form 8-K — filed 2017-06-30 — period 2017-06-27 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/enumeral-biomedical-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology